
A recent study analyzed data from 27,075 participants to investigate the link between proton pump inhibitor (PPI) use and kidney stones in US adults. The research, spanning 2007-2018, revealed a significant association between PPI use and kidney stones, with a 4% increase in prevalence for each additional year of PPI use. Recurrent kidney stones were also linked to PPI use, showing a 7% increase in recurrence for each extra year of use. These associations held even after propensity score matching. Subgroup analyses highlighted variations based on age, sex, race, and body mass index, emphasizing the concerning risks associated with prolonged PPI usage.
Like
Save
Share